Yarui Li

1.4k total citations
58 papers, 940 citations indexed

About

Yarui Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yarui Li has authored 58 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yarui Li's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (7 papers). Yarui Li is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (7 papers). Yarui Li collaborates with scholars based in China, Australia and United States. Yarui Li's co-authors include Mudan Ren, Shuixiang He, Dan Guo, Guifang Lu, Xinlan Lu, Yan Zhao, Dan Zhang, Guifang Lu, Yifei Chen and Shuixiang He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Yarui Li

52 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yarui Li China 18 526 369 130 122 66 58 940
Vikas Bhardwaj United States 18 427 0.8× 266 0.7× 85 0.7× 85 0.7× 181 2.7× 37 861
Shu‐Hui Lin Taiwan 22 548 1.0× 238 0.6× 105 0.8× 155 1.3× 363 5.5× 87 1.3k
Ping Wei China 18 491 0.9× 359 1.0× 295 2.3× 92 0.8× 232 3.5× 56 1.3k
Che Chen China 15 344 0.7× 143 0.4× 74 0.6× 81 0.7× 103 1.6× 44 728
Harald Enzmann Germany 20 364 0.7× 203 0.6× 93 0.7× 150 1.2× 235 3.6× 88 1.1k
Hajime Orita Japan 15 350 0.7× 252 0.7× 220 1.7× 239 2.0× 184 2.8× 96 863
Aram Oganesian United States 20 728 1.4× 111 0.3× 87 0.7× 42 0.3× 202 3.1× 56 1.2k
Haiping Yang China 22 694 1.3× 332 0.9× 275 2.1× 124 1.0× 235 3.6× 79 1.5k
Claudéte J. Valduga Brazil 16 443 0.8× 120 0.3× 51 0.4× 154 1.3× 112 1.7× 28 1.2k

Countries citing papers authored by Yarui Li

Since Specialization
Citations

This map shows the geographic impact of Yarui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yarui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yarui Li more than expected).

Fields of papers citing papers by Yarui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yarui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yarui Li. The network helps show where Yarui Li may publish in the future.

Co-authorship network of co-authors of Yarui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yarui Li. A scholar is included among the top collaborators of Yarui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yarui Li. Yarui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Zhihong, Lingli Wang, Yarui Li, et al.. (2025). Seasonal Variability and Pathogenicity of Kiwifruit Bacterial Canker Pathogens in Sichuan Province, China. Pathogens. 14(2). 191–191. 2 indexed citations
2.
3.
Lu, Huangjie, et al.. (2024). Dissolution‐Recrystallization: A Novel Mechanism for Fluorochromic Detection of Th4+ Using Color‐Tunable Luminescent Metal–Organic Frameworks. Angewandte Chemie International Edition. 63(46). 26 indexed citations
4.
Elhoumed, Mohamed, et al.. (2024). Dietary habits as associated factors with irritable bowel syndrome among medical students: evidence from a cross-sectional study. BMC Gastroenterology. 24(1). 268–268. 1 indexed citations
5.
6.
Zhang, Zhiyong, Yan Pan, Yan Zhao, et al.. (2023). RIPK2 promotes the progression of colon cancer by regulating BIRC3-mediated ubiquitination of IKBKG. Experimental Cell Research. 429(1). 113644–113644. 4 indexed citations
7.
Yu, Dengjie, et al.. (2023). Study on a modified spectral standardization method and quantitative analysis of cement based on microwave plasma torch. Journal of Analytical Atomic Spectrometry. 38(7). 1402–1411.
8.
Yao, Menglin, et al.. (2023). Exogenous hydrogen sulfide alleviates hepatic endoplasmic reticulum stress via SIRT1 / FoxO1 / PCSK9 pathway in NAFLD. The FASEB Journal. 37(8). e23027–e23027. 11 indexed citations
9.
Fan, Cailian, Hui Jie Zhang, Run Shi, et al.. (2023). A dual-channel fluorescence probe for simultaneously visualizing cysteine and viscosity during drug-induced hepatotoxicity. Heliyon. 9(11). e22276–e22276. 4 indexed citations
10.
Wang, Ruhua, Yunong Fu, Menglin Yao, et al.. (2022). The HN1 / HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. FEBS Journal. 289(20). 6400–6419. 17 indexed citations
11.
Zhang, Xu, Wenwen Chen, Dan Guo, et al.. (2022). Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis. Biological Procedures Online. 24(1). 14–14. 6 indexed citations
12.
Karim, Md Rezaul, et al.. (2022). Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial. Frontiers in Pharmacology. 13. 690726–690726. 16 indexed citations
13.
Karim, Md Rezaul, et al.. (2022). Role of H2 receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial. World Journal of Clinical Cases. 10(23). 8170–8185. 2 indexed citations
14.
He, Fei, et al.. (2021). NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma. BioMed Research International. 2021(1). 5954036–5954036. 15 indexed citations
15.
Feng, Lin, Mudan Ren, Yan Zhao, et al.. (2021). Colorectal Cancer Cell Differentiation Is Dependent on the Repression of Aerobic Glycolysis by NDRG2-TXNIP Axis. Digestive Diseases and Sciences. 67(8). 3763–3772. 14 indexed citations
16.
Zhao, Yan, Mudan Ren, Guifang Lu, et al.. (2020). The Prognosis Analysis of Liver Cirrhosis with Acute Variceal Bleeding and Validation of Current Prognostic Models: A Large Scale Retrospective Cohort Study. BioMed Research International. 2020(1). 7372868–7372868. 15 indexed citations
17.
Zhao, Yan, Yarui Li, Xin Wang, et al.. (2020). The Effect of <b><i>Helicobacter pylori</i></b> Eradication in Patients with Gastroesophageal Reflux Disease: A Meta-Analysis of Randomized Controlled Studies. Digestive Diseases. 38(4). 261–268. 28 indexed citations
18.
Li, Yarui, Dan Guo, Yan Zhao, et al.. (2018). Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway. Cell Death and Disease. 9(9). 888–888. 109 indexed citations
19.
Li, Yarui, Mudan Ren, Yan Zhao, et al.. (2017). MicroRNA-26a inhibits proliferation and metastasis of human hepatocellular carcinoma by regulating DNMT3B-MEG3 axis. Oncology Reports. 37(6). 3527–3535. 41 indexed citations
20.
Li, Yarui. (2009). The Expression and Clinical Significance of High Mobility Group Protein B1 in KD. China Modern Doctor. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vikas Bhardwaj Breakdown of academic impact, for papers by Shu‐Hui Lin Breakdown of academic impact, for papers by Ping Wei Breakdown of academic impact, for papers by Che Chen Breakdown of academic impact, for papers by Harald Enzmann Breakdown of academic impact, for papers by Hajime Orita Breakdown of academic impact, for papers by Aram Oganesian Breakdown of academic impact, for papers by Haiping Yang Breakdown of academic impact, for papers by Claudéte J. Valduga
Rankless by CCL
2026